Eisenmenger’s syndrome screening

Jump to navigation Jump to search

Eisenmenger’s syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eisenmenger’s syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Eisenmenger’s syndrome ACC/AHA Guidelines for Evaluation of Patients

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ACC/AHA Guidelines for Reproduction

Eisenmenger’s syndrome screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eisenmenger’s syndrome screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eisenmenger’s syndrome screening

CDC on Eisenmenger’s syndrome screening

Eisenmenger’s syndrome screening in the news

Blogs on Eisenmenger’s syndrome screening

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Eisenmenger’s syndrome screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]

Overview

There are currently no guidelines on using echocardiography to screen patients with CHD for the presence of pulmonary arterial hypertension. However, some parameters are recommended as pedictive for the development of pulmonary arterial hypertension, including peak tricuspid regurgitation velocity, ventricular basal diameter ratio, systolic and/or diastolic ventricular eccentricity index, RV outflow Doppler acceleration time, pulmonary artery diameter, and inferior vena cava inspiratory collapse.

Screening

    • Peak tricuspid regurgitation velocity
    • Ventricular basal diameter ratio
    • Systolic and/or diastolic ventricular eccentricity index.
    • RV outflow Doppler acceleration time
    • Pulmonary artery diameter
    • Inferior vena cava inspiratory collapse

References

  1. Dimopoulos K, Condliffe R, Tulloh RMR, Clift P, Alonso-Gonzalez R, Bedair R; et al. (2018). "Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease: JACC Review Topic of the Week". J Am Coll Cardiol. 72 (22): 2778–2788. doi:10.1016/j.jacc.2018.08.2201. PMID 30497564.

Template:WH Template:WS